FDA Adverse Event Injury Summary report: N

THV 1000-23 3F AORTIC BIO 23MM

MDR report key: 8016911 · Received October 29, 2018

Report

Report Number
3008592544-2018-00048
Event Type
Injury
Date Received
October 29, 2018
Date of Event
October 23, 2018
Report Date
October 29, 2018
Manufacturer
MEDTRONIC HEART VALVES DIVISION
Product Code
LWR
UDI-DI
00613994868237
PMA / PMN Number
P060025
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CONCLUSION: WITHOUT THE RETURN OF THE PRODUCT, NO DEFINITIVE CONCLUSION CAN BE MADE REGARDING THE CLINICAL OBSERVATION. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION THAT 7 YEARS AND 5 MONTHS POST IMPLANT OF THIS AORTIC BIOPROSTHETIC VALVE, A TRANSCATHETER VALVE WAS IMPLANTED VALVE-IN-VALVE DUE TO SEVERE INSUFFICIENCY. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
856839 THV 1000-23 3F AORTIC BIO 23MM HEART-VALVE, NON-ALLOGRAFT TISSUE LWR MEDTRONIC HEART VALVES DIVISION 1000-23 00613994868237

Patients

Seq Age Sex Outcome Treatment
1 79 YR Required Intervention